You just read:

BrainStorm Cell Therapeutics to Conduct Phase 2 Multi-Dose NurOwn® Trial in ALS at Hadassah Medical Center

News provided by

BrainStorm Cell Therapeutics Inc.

Jan 11, 2016, 07:30 ET